New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Moleculin Biotech, Inc.
MBRX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

7M

Biotechnology

Next Earning date - 11 Nov 2024

7M

Biotechnology

Next Earning date - 11 Nov 2024

2.44USD
Shape-0.09 ( -3.56%)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

-25%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

61%

Quote Panel

Shape
Updated October 12, 2024
1W -2.79 % 1M 0.41 % 3M -42.32 % 1Y -63.85 %

Key Metrics

Shape
  • Market Cap

    6.94M


  • Shares Outstanding

    2.84M


  • Share in Float

    2.74M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    2.44


  • Average Volume

    40103


  • Beta

    1.856


  • Range

    0.4-6.24


  • Industry

    Biotechnology


  • Website

    https://www.moleculin.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

17.03x

P/S Ratio

0.35x

P/B Ratio

0.0

Debt/Equity

-6198.8%

Net Margin

$-11.7

EPS

How MBRX compares to sector?

P/E Ratio

Relative Strength

Shape

MBRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$34M

ShapeNaN%

2025-Revenue

$5.89

Shape-247%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-4.50
vs -2.25

Q4.22

arrow
arrow

N/A

-3.60
vs -2.55

Q1.23

arrow
arrow

N/A

-4.20
vs -3.60

Q2.23

arrow
arrow

N/A

-3.00
vs -3.60

Q3.23

arrow
arrow

N/A

-2.85
vs -4.50

Q4.23

arrow
arrow

N/A

-5.02
vs -3.60

Q1.24

arrow
arrow

N/A

-2.02
vs -4.20

Q2.24

arrow
arrow

N/A

-2.23
vs -3.00

Q3.24

arrow
arrow

N/A

-2.44
vs -2.85

Q4.24

arrow
arrow

N/A

-1.54
vs -5.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

406K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-15%

-0.15
vs -0.10

Q4.22

arrow
arrow

-11%

-0.11
vs -0.15

Q1.23

arrow
arrow

-16%

-0.16
vs -0.11

Q2.23

arrow
arrow

-15%

-0.15
vs -0.16

Q3.23

arrow
arrow

-16%

-0.16
vs -0.15

Q4.23

arrow
arrow

-39%

-0.39
vs -0.16

Q1.24

arrow
arrow

-23%

-0.23
vs -0.39

Q2.24

arrow
arrow

-24%

-0.24
vs -0.23

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

21

21
vs 23

-9%

Q2.22

arrow
arrow

22

22
vs 21

5%

Q3.22

arrow
arrow

21

21
vs 22

-5%

Q4.22

arrow
arrow

24

24
vs 21

14%

Q1.23

arrow
arrow

23

23
vs 24

-4%

Q2.23

arrow
arrow

22

22
vs 23

-4%

Q3.23

arrow
arrow

20

20
vs 22

-9%

Q4.23

arrow
arrow

23

23
vs 20

15%

Earnings Growth

Latest News